Duration: (43:31) ?Subscribe5835 2025-02-19T07:36:53+00:00
Sequire Spotlight Presents: Dyadic International (DYAI) - Next Generation Proteins for World Health
(12:6)
Uncovering the Potential of Dyadic International: A Deep Dive into Innovative Biotechnology - UVI
(5:14)
Dyadic International, Inc. - Enzyme, Protein Products for Bioenergy, Industrial Enzyme, Biopharma
(5:9)
Dyadic International: Proteins for World Health DYAI NASDAQ detailed its product portfolio, vaccines
(17:6)
#DYAI #NASDAQ Dyadic International, Modernizing Influenza Vaccines in the USA #birdflu #influenza
(16:44)
#DYAI Dyadic,#Billgates Foundation Receives $3 Million Grant Ground breaking discovery #NASDAQ
(15:55)
Dyadic International, Inc Enzyme, Protein Products for Bioenergy, Industrial Enzyme, Biopharma
Dyadic International, Inc. Fireside Chat @ Lytham Partners Spring 2024 Investor Conference
(27:38)
Dyadic International disrupting the bio world with their C 1 technology
(3:55)
Dyadic International reveals newest research collaboration
(6:48)
Dyadic International teaming up top tier biopharmaceutical company
(4:50)
Dyadic International starts dosing in Phase 1 clinical trial DYAI-100 booster vaccine candidate
(6:32)
Dyadic International, Inc OTCQX DYAI
(4:6)
Dyadic International Fireside Chat @ Lytham Partners 2024 Investor Select Conference
(33:44)
Dyadic International to ring Nasdaq closing bell Part 1 of 2
(6:27)
Dyadic International, Inc. (NASDAQ: DYAI) | CEO Mark Emalfarb | Innovators with Jane King
(8:32)
Raising the Bar in NGS with Twist Bioscience
(1:36:12)
What is Happening Inside the Republic of Gilead? (A Map Analysis)
(9:)
MSD Ignition Controls - Playing with Fire
(6:7)
Saving Lives:Cheaper Vaccines 4 All #DYAI Dyadic #birdflu #healthcare #vaccine #wallstreet #nasdaq
(46)
Dyadic International says up listing to the NASDAQ is 'part of the plan'
(3:47)
Dyadic International posts higher revenue from R\u0026D, new sublicensing collaborations
(7:50)